Quantitative assessment of antimicrobial resistance in livestock during the course of a nationwide antimicrobial use reduction in the Netherlands.

OBJECTIVES To quantify associations between antimicrobial use and acquired resistance in indicator Escherichia coli over a period of time which involved sector-wide antimicrobial use reductions in broilers and pigs (years 2004-14), veal calves (2007-14) and dairy cattle (2005-14). Prevalence estimates of resistance were predicted for a hypothetical further decrease in antimicrobial use. METHODS Data reported annually for the resistance surveillance programme in the Netherlands were retrieved. Two multivariate random-effects logistic models per animal sector were used to relate total and class-specific antimicrobial use (as defined daily dosages per animal per year, DDDA/Y) with the probability of E. coli resistance to a panel of 10 antimicrobial agents. RESULTS Positive dose-response relationships (ORs) were obtained from all models. Specific resistance phenotypes were more often associated with total antimicrobial use than with class-specific use. The most robust associations were found in pigs and veal calves. Resistance to historically widely used antimicrobials (e.g. penicillins, tetracyclines) was, in relative terms, less influenced by drug use changes over time than resistance to newer or less prescribed antimicrobials (e.g. third-/fourth-generation cephalosporins, fluoroquinolones). In pigs and veal calves, prevalence estimates for the most common resistance phenotypes were projected to decline ∼5%-25% during 2014-16 if total antimicrobial use reduction reached 80%; projections for poultry and dairy cows were more modest. CONCLUSIONS Epidemiological evidence indicated that drug use history and co-selection of resistance are key elements for perpetuation of resistance. Data suggest that recent Dutch policies aimed at reducing total use of antimicrobials have decreased E. coli resistance in the pig and veal calf production sectors while the impact on the dairy cattle and poultry sectors is less clear.

[1]  D. Heederik,et al.  Impacts of Intensive Livestock Production on Human Health in Densely Populated Regions , 2017, GeoHealth.

[2]  Chantal Quinten,et al.  ECDC/EFSA/EMA second joint report on the integrated analysis of the consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food‐producing animals , 2017, EFSA journal. European Food Safety Authority.

[3]  The use of third and fourth generation cephalosporins affects the occurrence of extended-spectrum cephalosporinase-producing Escherichia coli in Danish pig herds. , 2015, Veterinary journal.

[4]  J. Wagenaar,et al.  Reduction of Veterinary Antimicrobial Use in the Netherlands. The Dutch Success Model , 2015, Zoonoses and public health.

[5]  D. Paterson,et al.  Do human extraintestinal Escherichia coli infections resistant to expanded-spectrum cephalosporins originate from food-producing animals? A systematic review. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  F. Aarestrup,et al.  Characterization of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli obtained from Danish pigs, pig farmers and their families from farms with high or no consumption of third- or fourth-generation cephalosporins. , 2014, The Journal of antimicrobial chemotherapy.

[7]  S. Börjesson,et al.  Vertical transmission of Escherichia coli carrying plasmid-mediated AmpC (pAmpC) through the broiler production pyramid. , 2014, The Journal of antimicrobial chemotherapy.

[8]  D. Heederik,et al.  Reduction of antibiotic use in animals “let’s go Dutch” , 2014, Journal für Verbraucherschutz und Lebensmittelsicherheit.

[9]  J. Dewulf,et al.  Correlation between veterinary antimicrobial use and antimicrobial resistance in food-producing animals: a report on seven countries. , 2014, The Journal of antimicrobial chemotherapy.

[10]  Herman Goossens,et al.  A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance , 2014, BMC Infectious Diseases.

[11]  J. Wagenaar,et al.  Antimicrobial resistance in commensal Escherichia coli in veal calves is associated with antimicrobial drug use , 2013, Epidemiology and Infection.

[12]  Shaohua Zhao,et al.  Antimicrobial Drug Resistance in Escherichia coli from Humans and Food Animals, United States, 1950–2002 , 2012, Emerging infectious diseases.

[13]  M. Falagas,et al.  Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[14]  D. Mackay,et al.  Comparison of the sales of veterinary antibacterial agents between 10 European countries. , 2010, The Journal of antimicrobial chemotherapy.

[15]  A. Rajić,et al.  Associations between reported on-farm antimicrobial use practices and observed antimicrobial resistance in generic fecal Escherichia coli isolated from Alberta finishing swine farms. , 2009, Preventive veterinary medicine.

[16]  M. Wierup,et al.  Antimicrobial Resistance in Scandinavia after a Ban of Antimicrobial Growth Promoters , 2006, Animal biotechnology.

[17]  J. E. Olsen,et al.  Vertical transmission of a fluoroquinolone-resistant Escherichia coli within an integrated broiler operation. , 2006, Veterinary microbiology.

[18]  V. Jensen,et al.  Usage of veterinary therapeutic antimicrobials in Denmark, Norway and Sweden following termination of antimicrobial growth promoter use. , 2006, Preventive veterinary medicine.

[19]  T. Asai,et al.  Correlation between the usage volume of veterinary therapeutic antimicrobials and resistance in Escherichia coli isolated from the feces of food-producing animals in Japan. , 2005, Japanese journal of infectious diseases.

[20]  F. Baquero,et al.  European recommendations for antimicrobial resistance surveillance. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[21]  P. Ebner,et al.  Characterization of resistance patterns and detection of apramycin resistance genes in Escherichia coli isolated from swine exposed to various environmental conditions. , 2003, International journal of food microbiology.

[22]  T. O'Brien.  Emergence, spread, and environmental effect of antimicrobial resistance: how use of an antimicrobial anywhere can increase resistance to any antimicrobial anywhere else. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  P. Fedorka-Cray,et al.  Antimicrobial use and resistance in animals. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  B. E. Langlois,et al.  Antimicrobial resistance of gram-negative enteric bacteria from pigs in a nonantimicrobial-exposed herd before and after transportation. , 1999, Journal of food protection.

[25]  L. Ge,et al.  Trends in veterinary antibiotic use in the Netherlands 2005-2011 , 2012 .

[26]  H.C.J. Vrolijk,et al.  Sample of Dutch FADN 2007; design principles and quality of the sample of agricultural and horticultural holdings. , 2009 .

[27]  S. McEwen,et al.  Associations of antimicrobial uses with antimicrobial resistance of fecal Escherichia coli from pigs on 47 farrow-to-finish farms in Ontario and British Columbia. , 2008, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.

[28]  A. Hensel,et al.  RESEARCH ARTICLE Open Access Factors associated with the occurrence of MRSA CC398 in herds of fattening pigs in Germany , 2022 .

[29]  D. Heederik,et al.  Emerging Blockininfectious Blockindiseases Blockin@bullet Blockin Dose-response Relationship between Antimicrobial Drugs and Livestock-associated Mrsa in Pig Farming 1 , 2022 .